These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22328053)

  • 1. Biographical data of patients in drug substitution programmes.
    Tönies H
    Wien Med Wochenschr; 2012 Jan; 162(1-2):39-43. PubMed ID: 22328053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current consumer conditions among opioid addicts--implications for maintenance-treatment programmes provided by ambulatory drug treatment centers and physicians].
    Giacomuzzi SM; Ertl M; Riemer Y; Rössler H; Vigl A; Hinterhuber H; Kurz M
    Wien Klin Wochenschr; 2004 Feb; 116(4):119-27. PubMed ID: 15038402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response: an insidious dependence.
    Mackin D; Martin C; McGavin JK
    Addict Sci Clin Pract; 2007 Dec; 4(1):16-8. PubMed ID: 18292705
    [No Abstract]   [Full Text] [Related]  

  • 4. Opioid substitution treatment reduces substance use equivalently in patients with and without posttraumatic stress disorder.
    Trafton JA; Minkel J; Humphreys K
    J Stud Alcohol; 2006 Mar; 67(2):228-35. PubMed ID: 16562404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug use and dependence in cocaine dependent subjects, community-based individuals, and their siblings.
    Bierut LJ; Strickland JR; Thompson JR; Afful SE; Cottler LB
    Drug Alcohol Depend; 2008 May; 95(1-2):14-22. PubMed ID: 18243582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
    Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
    J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of psychotic symptoms in substance users: a comparison across substances.
    Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
    Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS).
    Hubbard RL; Craddock SG; Anderson J
    J Subst Abuse Treat; 2003 Oct; 25(3):125-34. PubMed ID: 14670518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
    Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
    Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003).
    Peretti-Watel P; Spire B; Lert F; Obadia Y;
    Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S71-9. PubMed ID: 16769450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis C within a heroine-assisted treatment program].
    Deibler P; Haasen C; Reimer J
    Dtsch Med Wochenschr; 2006 Dec; 131(50):2835-7. PubMed ID: 17160765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cannabis withdrawal syndrome in patients with cannabis dependence only, and in patients with cannabis and opioid dependence].
    Vorspan F; Guillem E; Bloch V; Bellais L; Sicot R; Noble F; Lepine JP; Gorelick DA
    Encephale; 2011 Sep; 37(4):266-72. PubMed ID: 21981886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pregnant opioid addicted patients and additional drug intake. Part I. Toxic effects and therapeutic consequences].
    Hoell I; Havemann-Reinecke U
    Med Monatsschr Pharm; 2011 Oct; 34(10):363-74; quiz 375-6. PubMed ID: 22010420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Co-morbidity: psychiatric disorder of opiate addicts at entry into heroin-assisted treatment].
    Frei A; Rehm J;
    Psychiatr Prax; 2002 Jul; 29(5):251-7. PubMed ID: 12101491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A latent class approach to treatment readiness corresponds to a transtheoretical ("Stages of Change") model.
    Harrell PT; Trenz RC; Scherer M; Martins SS; Latimer WW
    J Subst Abuse Treat; 2013 Sep; 45(3):249-56. PubMed ID: 23706606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine for human immunovirus-positive opiate-dependent patients.
    Montoya ID; Umbricht A; Preston KL
    Biol Psychiatry; 1995 Jul; 38(2):135-6. PubMed ID: 7578651
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.
    Serino Ma D; Peterson Md BS; Rosen Md TS
    J Dual Diagn; 2018; 14(3):158-170. PubMed ID: 29694295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?
    Taylor LE; Maynard MA; Friedmann PD; Macleod CJ; Rich JD; Flanigan TP; Sylvestre DL
    J Addict Med; 2012 Sep; 6(3):179-85. PubMed ID: 22614935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Substitution as a possibility for the treatment of opiate dependent patients].
    von Bardeleben U; Petitjean S; Stohler R; Natsch C; Ladewig D
    Psychiatr Prax; 1994 Jan; 21(1):7-9. PubMed ID: 8146246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
    Betts KS; Chan G; McIlwraith F; Dietze P; Whittaker E; Burns L; Alati R
    Addiction; 2016 Jul; 111(7):1214-23. PubMed ID: 26857811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.